These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 12913692

  • 1. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M.
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [Abstract] [Full Text] [Related]

  • 3. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A, Serni S, Giubilei G, Lanzi F, Vittori G, Lapini A, Carini M.
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [Abstract] [Full Text] [Related]

  • 4. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML.
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [Abstract] [Full Text] [Related]

  • 6. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG.
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [Abstract] [Full Text] [Related]

  • 7. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [Abstract] [Full Text] [Related]

  • 8. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 9. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
    Hutterer GC, Patard JJ, Colombel M, Belldegrun AS, Pfister C, Guille F, Artibani W, Montorsi F, Pantuck AJ, Karakiewicz PI.
    Cancer; 2007 Dec 01; 110(11):2428-33. PubMed ID: 17941033
    [Abstract] [Full Text] [Related]

  • 10. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.
    Urology; 2010 Feb 01; 75(2):271-5. PubMed ID: 19962740
    [Abstract] [Full Text] [Related]

  • 11. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr 01; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 12. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H.
    J Urol; 1996 Jun 01; 155(6):1868-73. PubMed ID: 8618276
    [Abstract] [Full Text] [Related]

  • 13. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML.
    Eur Urol; 2008 Oct 01; 54(4):855-63. PubMed ID: 18487007
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M.
    Ann Surg Oncol; 2010 Feb 01; 17(2):544-51. PubMed ID: 19953334
    [Abstract] [Full Text] [Related]

  • 15. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R, European Organization for Research and Treatment of Cancer (EORTC), National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), Southwest Oncology Group (SWOG), Eastern Cooperative Oncology Group (ECOG).
    Eur Urol; 2007 Jun 01; 51(6):1606-15. PubMed ID: 17140723
    [Abstract] [Full Text] [Related]

  • 16. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.
    Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thüroff JW.
    J Urol; 2006 Jun 01; 175(6):2027-31. PubMed ID: 16697793
    [Abstract] [Full Text] [Related]

  • 17. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
    Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML.
    J Urol; 2005 Feb 01; 173(2):391-4. PubMed ID: 15643178
    [Abstract] [Full Text] [Related]

  • 18. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul 01; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 19. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
    Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, Benoit G.
    Urology; 2007 Sep 01; 70(3):435-9. PubMed ID: 17905091
    [Abstract] [Full Text] [Related]

  • 20. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun 01; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.